These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6161631)

  • 1. Immunological characterization of endocervical mucus in normal and neoplastic tissue.
    Cauchi MN; Lim D; Giddy M
    Br J Cancer; 1981 Jan; 43(1):108-10. PubMed ID: 6161631
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of MAM-3 and MAM-6 antigens in endometrial and endocervical adenocarcinomas.
    Tsubura A; Morii S; Hilkens J; Hilgers J
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(1):59-67. PubMed ID: 3925626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local immunological response in the vagina, cervix and endometrium.
    Vaerman JP; Férin J
    Acta Endocrinol Suppl (Copenh); 1975; 194():281-305. PubMed ID: 1092117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uterine cervix as a potential local antibody secretor.
    Hulka JF; Omran KF
    Am J Obstet Gynecol; 1969 Jun; 104(3):440-2. PubMed ID: 4181528
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue CEA test in endocervical and endometrial adenocarcinoma.
    Wahlström T; Seppälä M
    Lancet; 1980 Mar; 1(8168 Pt 1):597. PubMed ID: 6102317
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
    Ohwada M; Suzuki M; Tamada T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulins and secretory component in endometrium and cervix. Influence of inflammation and carcinoma.
    Hurlimann J; Dayal R; Gloor E
    Virchows Arch A Pathol Anat Histol; 1978 Mar; 377(3):211-23. PubMed ID: 148150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin concentrations in cervical mucus in patients with normal and abnormal cervical cytology.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Feb; 84(2):129-34. PubMed ID: 843479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoglobulin levels in cervical mucus in patients with grade Io cancer of the cervix uteri and precancerous conditions].
    Pilawski Z; Sieja K; Uzar A
    Ginekol Pol; 1985 Jan; 56(1):1-4. PubMed ID: 4018622
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic similarities between respiratory and reproductive tract mucins: heterogeneity of mucin expression by human endocervix and endometrium.
    D'Cruz OJ; Wild RA; Medders DE; Padhye NV; Sachdev GP
    Fertil Steril; 1993 Dec; 60(6):1011-9. PubMed ID: 7694876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
    Ferguson A; Moore M; Fox H
    Br J Cancer; 1985 Oct; 52(4):551-63. PubMed ID: 2415145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premalignant and malignant uterine changes in immunosuppressed renal transplant recipients.
    Husslein H; Breitenecker G; Tatra G
    Acta Obstet Gynecol Scand; 1978; 57(1):73-8. PubMed ID: 341640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic reactivity with the monoclonal antibody HMFG1 as a marker of cervical glandular atypia.
    Brown LJ; Griffin NR; Wells M
    J Pathol; 1987 Mar; 151(3):203-8. PubMed ID: 3572614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.
    Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K
    Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor marker CA 125 is a common constituent of normal cervical mucus.
    de Bruijn HW; van Beeck Calkoen-Carpay T; Jager S; Duk JM; Aalders JG; Fleuren GJ
    Am J Obstet Gynecol; 1986 May; 154(5):1088-91. PubMed ID: 2422937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of carcinoembryonic antigen in uterine cervical neoplasia.
    Agarwal S; Sharma S
    Indian J Med Res; 1990 Dec; 92():452-5. PubMed ID: 2079363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue CEA test in endocervical and endometrial adenocarcinoma.
    Dufour DR; Stock RJ
    Lancet; 1980 Mar; 1(8168 Pt 1):596-7. PubMed ID: 6102315
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of the immunological factor in the sterility of cervical origin. Clinical data and terapeutic trends.
    Scarselli G; Pala AM; Tonini M; Chelo E; Tantini C
    Acta Eur Fertil; 1979 Mar; 10(1):35-40. PubMed ID: 397706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum CA125 and CA19-9 levels in adenocarcinoma of the uterine cervix and endometrial carcinoma].
    Ihara Y; Shimizu T; Kawaguchi K; Yomura W; Fujiwara T; Inoue K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1711-8. PubMed ID: 3235884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.